Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

The diversity of the general population is an important factor when determining the effectiveness of a new therapy. Although many trials are conducted on so-called experimental treatments, many ...

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

Pharma is understandably risk-averse, and many companies remain in pilot mode, running small experiments that never scale.

Merck's CEO Rob Davis emphasizes DEI as a strategic imperative, aligning it with scientific rigor and innovation, showcasing ...

With populations aging, chronic diseases becoming more prevalent, and global health experts warning of potential pandemics, the need for rapid therapeutic development has reached unprecedented levels.

The IMROZ and PERSEUS trials revealed significant underrepresentation of Black patients, despite their high incidence of multiple myeloma. Broader underrepresentation of minority groups in clinical ...

BOSTON--(BUSINESS WIRE)--Adams Clinical, LLC (“Adams”, or the “Company”), a leading Neuroscience-focused clinical trial site network announced today that it has agreed on terms of the intent to ...

Choosing the right EDC (electronic data capture) platform is critical for sponsors, CROs, and clinical operations teams ...